Matches in SemOpenAlex for { <https://semopenalex.org/work/W2321504443> ?p ?o ?g. }
- W2321504443 endingPage "519" @default.
- W2321504443 startingPage "515" @default.
- W2321504443 abstract "Summary The 2005 International Society of Urological Pathology (ISUP) modified Gleason grading system was further amended in 2014 with the establishment of grade groupings (ISUP grading). This study examined the predictive value of ISUP grading, comparing results with recognised prognostic parameters. Of 3700 men undergoing radical prostatectomy (RP) reported at Aquesta Pathology between 2008 and 2013, 2079 also had a positive needle biopsy available for review. We examined the association between needle biopsy 2014 ISUP grade and 2005 modified Gleason score, tumour volume, pathological stage of the subsequent RP tumour, as well as biochemical recurrence-free survival (BRFS). The median age was 62 (range 32–79 years). Median serum prostate specific antigen was 5.9 (range 0.4–69 ng/mL). For needle biopsies, 280 (13.5%), 1031 (49.6%), 366 (17.6%), 77 (3.7%) and 325 (15.6%) were 2014 ISUP grades 1–5, respectively. Needle biopsy 2014 ISUP grade showed a significant association with RP tumour volume (p < 0.001), TNM pT and N stage (p < 0.001) and BRFS (p < 0.001). Multivariate analysis using Cox proportional hazards regression model showed serum prostate specific antigen (PSA) at the time of diagnosis and ISUP grade >2 to be significantly associated with BRFS. This study provides evidence of the prognostic significance of ISUP grading for thin core needle biopsy of prostate. The 2005 International Society of Urological Pathology (ISUP) modified Gleason grading system was further amended in 2014 with the establishment of grade groupings (ISUP grading). This study examined the predictive value of ISUP grading, comparing results with recognised prognostic parameters. Of 3700 men undergoing radical prostatectomy (RP) reported at Aquesta Pathology between 2008 and 2013, 2079 also had a positive needle biopsy available for review. We examined the association between needle biopsy 2014 ISUP grade and 2005 modified Gleason score, tumour volume, pathological stage of the subsequent RP tumour, as well as biochemical recurrence-free survival (BRFS). The median age was 62 (range 32–79 years). Median serum prostate specific antigen was 5.9 (range 0.4–69 ng/mL). For needle biopsies, 280 (13.5%), 1031 (49.6%), 366 (17.6%), 77 (3.7%) and 325 (15.6%) were 2014 ISUP grades 1–5, respectively. Needle biopsy 2014 ISUP grade showed a significant association with RP tumour volume (p < 0.001), TNM pT and N stage (p < 0.001) and BRFS (p < 0.001). Multivariate analysis using Cox proportional hazards regression model showed serum prostate specific antigen (PSA) at the time of diagnosis and ISUP grade >2 to be significantly associated with BRFS. This study provides evidence of the prognostic significance of ISUP grading for thin core needle biopsy of prostate." @default.
- W2321504443 created "2016-06-24" @default.
- W2321504443 creator A5016168279 @default.
- W2321504443 creator A5024491127 @default.
- W2321504443 creator A5024616322 @default.
- W2321504443 creator A5031622757 @default.
- W2321504443 creator A5034554281 @default.
- W2321504443 creator A5045527532 @default.
- W2321504443 creator A5051094983 @default.
- W2321504443 creator A5074322490 @default.
- W2321504443 creator A5080563805 @default.
- W2321504443 date "2015-10-01" @default.
- W2321504443 modified "2023-10-16" @default.
- W2321504443 title "The prognostic significance of the 2014 International Society of Urological Pathology (ISUP) grading system for prostate cancer" @default.
- W2321504443 cites W1608188497 @default.
- W2321504443 cites W1970173349 @default.
- W2321504443 cites W1976133111 @default.
- W2321504443 cites W1978761040 @default.
- W2321504443 cites W1996098370 @default.
- W2321504443 cites W2000872665 @default.
- W2321504443 cites W2006115709 @default.
- W2321504443 cites W2007056369 @default.
- W2321504443 cites W2010090348 @default.
- W2321504443 cites W2011111398 @default.
- W2321504443 cites W2014610851 @default.
- W2321504443 cites W2023922025 @default.
- W2321504443 cites W2034197778 @default.
- W2321504443 cites W2048129268 @default.
- W2321504443 cites W2049032356 @default.
- W2321504443 cites W2058027936 @default.
- W2321504443 cites W2062811587 @default.
- W2321504443 cites W2076099429 @default.
- W2321504443 cites W2078865559 @default.
- W2321504443 cites W2083043726 @default.
- W2321504443 cites W2087349778 @default.
- W2321504443 cites W2087532179 @default.
- W2321504443 cites W2090989685 @default.
- W2321504443 cites W2100185563 @default.
- W2321504443 cites W2115845390 @default.
- W2321504443 cites W2148329056 @default.
- W2321504443 cites W2148511209 @default.
- W2321504443 cites W2165544861 @default.
- W2321504443 cites W2314727742 @default.
- W2321504443 cites W4255804705 @default.
- W2321504443 doi "https://doi.org/10.1097/pat.0000000000000315" @default.
- W2321504443 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26325670" @default.
- W2321504443 hasPublicationYear "2015" @default.
- W2321504443 type Work @default.
- W2321504443 sameAs 2321504443 @default.
- W2321504443 citedByCount "49" @default.
- W2321504443 countsByYear W23215044432015 @default.
- W2321504443 countsByYear W23215044432016 @default.
- W2321504443 countsByYear W23215044432017 @default.
- W2321504443 countsByYear W23215044432018 @default.
- W2321504443 countsByYear W23215044432019 @default.
- W2321504443 countsByYear W23215044432020 @default.
- W2321504443 countsByYear W23215044432021 @default.
- W2321504443 countsByYear W23215044432022 @default.
- W2321504443 countsByYear W23215044432023 @default.
- W2321504443 crossrefType "journal-article" @default.
- W2321504443 hasAuthorship W2321504443A5016168279 @default.
- W2321504443 hasAuthorship W2321504443A5024491127 @default.
- W2321504443 hasAuthorship W2321504443A5024616322 @default.
- W2321504443 hasAuthorship W2321504443A5031622757 @default.
- W2321504443 hasAuthorship W2321504443A5034554281 @default.
- W2321504443 hasAuthorship W2321504443A5045527532 @default.
- W2321504443 hasAuthorship W2321504443A5051094983 @default.
- W2321504443 hasAuthorship W2321504443A5074322490 @default.
- W2321504443 hasAuthorship W2321504443A5080563805 @default.
- W2321504443 hasConcept C121608353 @default.
- W2321504443 hasConcept C126322002 @default.
- W2321504443 hasConcept C126894567 @default.
- W2321504443 hasConcept C127413603 @default.
- W2321504443 hasConcept C142724271 @default.
- W2321504443 hasConcept C147176958 @default.
- W2321504443 hasConcept C2775934546 @default.
- W2321504443 hasConcept C2776235491 @default.
- W2321504443 hasConcept C2777286243 @default.
- W2321504443 hasConcept C2779466945 @default.
- W2321504443 hasConcept C2780192828 @default.
- W2321504443 hasConcept C2781406297 @default.
- W2321504443 hasConcept C50382708 @default.
- W2321504443 hasConcept C71924100 @default.
- W2321504443 hasConceptScore W2321504443C121608353 @default.
- W2321504443 hasConceptScore W2321504443C126322002 @default.
- W2321504443 hasConceptScore W2321504443C126894567 @default.
- W2321504443 hasConceptScore W2321504443C127413603 @default.
- W2321504443 hasConceptScore W2321504443C142724271 @default.
- W2321504443 hasConceptScore W2321504443C147176958 @default.
- W2321504443 hasConceptScore W2321504443C2775934546 @default.
- W2321504443 hasConceptScore W2321504443C2776235491 @default.
- W2321504443 hasConceptScore W2321504443C2777286243 @default.
- W2321504443 hasConceptScore W2321504443C2779466945 @default.
- W2321504443 hasConceptScore W2321504443C2780192828 @default.
- W2321504443 hasConceptScore W2321504443C2781406297 @default.
- W2321504443 hasConceptScore W2321504443C50382708 @default.
- W2321504443 hasConceptScore W2321504443C71924100 @default.
- W2321504443 hasIssue "6" @default.